> top > docs > PubMed:20105310 > annotations

PubMed:20105310 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-144 Sentence denotes Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects.
T2 145-156 Sentence denotes BACKGROUND:
T3 157-217 Sentence denotes Prevalence of obesity is increasing to pandemic proportions.
T4 218-312 Sentence denotes However, obese subjects differ in insulin resistance, adipokine production and co-morbidities.
T5 313-471 Sentence denotes Based on fasting plasma analysis, obese subjects were grouped as Low Acylation Stimulating protein (ASP) and Triglyceride (TG) (LAT) vs High ASP and TG (HAT).
T6 472-647 Sentence denotes Subcutaneous (SC) and omental (OM) adipose tissues (n = 21) were analysed by microarray, and biologic pathways in lipid metabolism and inflammation were specifically examined.
T7 648-794 Sentence denotes METHODS: LAT and HAT groups were matched in age, obesity, insulin, and glucose, and had similar expression of insulin-related genes (InsR, IRS-1).
T8 795-923 Sentence denotes ASP related genes tended to be increased in the HAT group and were correlated (factor B, adipsin, complement C3, p < 0.01 each).
T9 924-1036 Sentence denotes Differences between LAT and HAT group were almost exclusively in SC tissue, with little difference in OM tissue.
T10 1037-1162 Sentence denotes Increased C5L2 (p < 0.01), an ASP receptor, in HAT suggests a compensatory ASP pathway, associated with increased TG storage.
T11 1163-1437 Sentence denotes RESULTS: HAT adipose tissue demonstrated increased lipid related genes for storage (CD36, DGAT1, DGAT2, SCD1, FASN, and LPL), lipolysis (HSL, CES1, perilipin), fatty acid binding proteins (FABP1, FABP3) and adipocyte differentiation markers (CEBPalpha, CEBPbeta, PPARgamma).
T12 1438-1516 Sentence denotes By contrast, oxidation related genes were decreased (AMPK, UCP1, CPT1, FABP7).
T13 1517-1691 Sentence denotes HAT subjects had increased anti-inflammatory genes TGFB1, TIMP1, TIMP3, and TIMP4 while proinflammatory PIG7 and MMP2 were also significantly increased; all genes, p < 0.025.
T14 1692-1703 Sentence denotes CONCLUSION:
T15 1704-1924 Sentence denotes Taken together, the profile of C5L2 receptor, ASP gene expression and metabolic factors in adipose tissue from morbidly obese HAT subjects suggests a compensatory response associated with the increased plasma ASP and TG.
T1 0-144 Sentence denotes Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects.
T2 145-156 Sentence denotes BACKGROUND:
T3 157-217 Sentence denotes Prevalence of obesity is increasing to pandemic proportions.
T4 218-312 Sentence denotes However, obese subjects differ in insulin resistance, adipokine production and co-morbidities.
T5 313-471 Sentence denotes Based on fasting plasma analysis, obese subjects were grouped as Low Acylation Stimulating protein (ASP) and Triglyceride (TG) (LAT) vs High ASP and TG (HAT).
T6 472-647 Sentence denotes Subcutaneous (SC) and omental (OM) adipose tissues (n = 21) were analysed by microarray, and biologic pathways in lipid metabolism and inflammation were specifically examined.
T7 648-794 Sentence denotes METHODS: LAT and HAT groups were matched in age, obesity, insulin, and glucose, and had similar expression of insulin-related genes (InsR, IRS-1).
T8 795-923 Sentence denotes ASP related genes tended to be increased in the HAT group and were correlated (factor B, adipsin, complement C3, p < 0.01 each).
T9 924-1036 Sentence denotes Differences between LAT and HAT group were almost exclusively in SC tissue, with little difference in OM tissue.
T10 1037-1162 Sentence denotes Increased C5L2 (p < 0.01), an ASP receptor, in HAT suggests a compensatory ASP pathway, associated with increased TG storage.
T11 1163-1437 Sentence denotes RESULTS: HAT adipose tissue demonstrated increased lipid related genes for storage (CD36, DGAT1, DGAT2, SCD1, FASN, and LPL), lipolysis (HSL, CES1, perilipin), fatty acid binding proteins (FABP1, FABP3) and adipocyte differentiation markers (CEBPalpha, CEBPbeta, PPARgamma).
T12 1438-1516 Sentence denotes By contrast, oxidation related genes were decreased (AMPK, UCP1, CPT1, FABP7).
T13 1517-1691 Sentence denotes HAT subjects had increased anti-inflammatory genes TGFB1, TIMP1, TIMP3, and TIMP4 while proinflammatory PIG7 and MMP2 were also significantly increased; all genes, p < 0.025.
T14 1692-1703 Sentence denotes CONCLUSION:
T15 1704-1924 Sentence denotes Taken together, the profile of C5L2 receptor, ASP gene expression and metabolic factors in adipose tissue from morbidly obese HAT subjects suggests a compensatory response associated with the increased plasma ASP and TG.

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-144 Sentence denotes Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects.
T2 145-156 Sentence denotes BACKGROUND:
T3 157-217 Sentence denotes Prevalence of obesity is increasing to pandemic proportions.
T4 218-312 Sentence denotes However, obese subjects differ in insulin resistance, adipokine production and co-morbidities.
T5 313-471 Sentence denotes Based on fasting plasma analysis, obese subjects were grouped as Low Acylation Stimulating protein (ASP) and Triglyceride (TG) (LAT) vs High ASP and TG (HAT).
T6 472-647 Sentence denotes Subcutaneous (SC) and omental (OM) adipose tissues (n = 21) were analysed by microarray, and biologic pathways in lipid metabolism and inflammation were specifically examined.
T7 648-794 Sentence denotes METHODS: LAT and HAT groups were matched in age, obesity, insulin, and glucose, and had similar expression of insulin-related genes (InsR, IRS-1).
T8 795-923 Sentence denotes ASP related genes tended to be increased in the HAT group and were correlated (factor B, adipsin, complement C3, p < 0.01 each).
T9 924-1036 Sentence denotes Differences between LAT and HAT group were almost exclusively in SC tissue, with little difference in OM tissue.
T10 1037-1162 Sentence denotes Increased C5L2 (p < 0.01), an ASP receptor, in HAT suggests a compensatory ASP pathway, associated with increased TG storage.
T11 1163-1437 Sentence denotes RESULTS: HAT adipose tissue demonstrated increased lipid related genes for storage (CD36, DGAT1, DGAT2, SCD1, FASN, and LPL), lipolysis (HSL, CES1, perilipin), fatty acid binding proteins (FABP1, FABP3) and adipocyte differentiation markers (CEBPalpha, CEBPbeta, PPARgamma).
T12 1438-1516 Sentence denotes By contrast, oxidation related genes were decreased (AMPK, UCP1, CPT1, FABP7).
T13 1517-1691 Sentence denotes HAT subjects had increased anti-inflammatory genes TGFB1, TIMP1, TIMP3, and TIMP4 while proinflammatory PIG7 and MMP2 were also significantly increased; all genes, p < 0.025.
T14 1692-1703 Sentence denotes CONCLUSION:
T15 1704-1924 Sentence denotes Taken together, the profile of C5L2 receptor, ASP gene expression and metabolic factors in adipose tissue from morbidly obese HAT subjects suggests a compensatory response associated with the increased plasma ASP and TG.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
7009 36-39 GeneOrGeneProduct denotes ASP NCBIGene:718
7010 129-134 DiseaseOrPhenotypicFeature denotes obese MESH:D009765
7011 171-178 DiseaseOrPhenotypicFeature denotes obesity MESH:D009765
7012 227-232 DiseaseOrPhenotypicFeature denotes obese MESH:D009765
7013 252-270 DiseaseOrPhenotypicFeature denotes insulin resistance MESH:D007333
7014 272-281 GeneOrGeneProduct denotes adipokine NCBIGene:9370
7015 347-352 DiseaseOrPhenotypicFeature denotes obese MESH:D009765
7016 382-411 GeneOrGeneProduct denotes Acylation Stimulating protein NCBIGene:718
7017 413-416 GeneOrGeneProduct denotes ASP NCBIGene:718
7018 422-434 ChemicalEntity denotes Triglyceride MESH:D014280
7019 436-438 ChemicalEntity denotes TG MESH:D014280
7020 454-457 GeneOrGeneProduct denotes ASP NCBIGene:718
7021 462-464 ChemicalEntity denotes TG MESH:D014280
7022 586-591 ChemicalEntity denotes lipid MESH:D008055
7023 607-619 DiseaseOrPhenotypicFeature denotes inflammation MESH:D007249
7024 697-704 DiseaseOrPhenotypicFeature denotes obesity MESH:D009765
7025 706-713 GeneOrGeneProduct denotes insulin NCBIGene:3630
7026 719-726 ChemicalEntity denotes glucose MESH:D005947
7027 758-765 GeneOrGeneProduct denotes insulin NCBIGene:3630
7028 781-785 GeneOrGeneProduct denotes InsR NCBIGene:3643
7029 787-792 GeneOrGeneProduct denotes IRS-1 NCBIGene:3667
7030 795-798 GeneOrGeneProduct denotes ASP NCBIGene:718
7031 874-882 GeneOrGeneProduct denotes factor B NCBIGene:629
7032 884-891 GeneOrGeneProduct denotes adipsin NCBIGene:1675
7033 893-906 GeneOrGeneProduct denotes complement C3 NCBIGene:718
7034 1047-1051 GeneOrGeneProduct denotes C5L2 NCBIGene:27202
7035 1067-1079 GeneOrGeneProduct denotes ASP receptor NCBIGene:27202
7036 1112-1115 GeneOrGeneProduct denotes ASP NCBIGene:718
7037 1151-1153 ChemicalEntity denotes TG MESH:D014280
7038 1214-1219 ChemicalEntity denotes lipid MESH:D008055
7039 1247-1251 GeneOrGeneProduct denotes CD36 NCBIGene:948
7040 1253-1258 GeneOrGeneProduct denotes DGAT1 NCBIGene:8694
7041 1260-1265 GeneOrGeneProduct denotes DGAT2 NCBIGene:84649
7042 1267-1271 GeneOrGeneProduct denotes SCD1 NCBIGene:6319
7043 1273-1277 GeneOrGeneProduct denotes FASN NCBIGene:2194
7044 1283-1286 GeneOrGeneProduct denotes LPL NCBIGene:4023
7045 1300-1303 GeneOrGeneProduct denotes HSL NCBIGene:3991
7046 1305-1309 GeneOrGeneProduct denotes CES1 NCBIGene:1066
7047 1311-1320 GeneOrGeneProduct denotes perilipin NCBIGene:5346
7048 1323-1350 GeneOrGeneProduct denotes fatty acid binding proteins NCBIGene:2168|NCBIGene:2170
7049 1352-1357 GeneOrGeneProduct denotes FABP1 NCBIGene:2168
7050 1359-1364 GeneOrGeneProduct denotes FABP3 NCBIGene:2170
7051 1405-1414 GeneOrGeneProduct denotes CEBPalpha NCBIGene:1050
7052 1416-1424 GeneOrGeneProduct denotes CEBPbeta NCBIGene:1051
7053 1426-1435 GeneOrGeneProduct denotes PPARgamma NCBIGene:5468
7054 1491-1495 GeneOrGeneProduct denotes AMPK NCBIGene:5562
7055 1497-1501 GeneOrGeneProduct denotes UCP1 NCBIGene:7350
7056 1503-1507 GeneOrGeneProduct denotes CPT1 NCBIGene:1374
7057 1509-1514 GeneOrGeneProduct denotes FABP7 NCBIGene:2173
7058 1549-1561 DiseaseOrPhenotypicFeature denotes inflammatory MESH:D007249
7059 1568-1573 GeneOrGeneProduct denotes TGFB1 NCBIGene:7040
7060 1575-1580 GeneOrGeneProduct denotes TIMP1 NCBIGene:7076
7061 1582-1587 GeneOrGeneProduct denotes TIMP3 NCBIGene:7078
7062 1593-1598 GeneOrGeneProduct denotes TIMP4 NCBIGene:7079
7063 1605-1620 DiseaseOrPhenotypicFeature denotes proinflammatory MESH:D007249
7064 1621-1625 GeneOrGeneProduct denotes PIG7 NCBIGene:9516
7065 1630-1634 GeneOrGeneProduct denotes MMP2 NCBIGene:4313
7066 1735-1739 GeneOrGeneProduct denotes C5L2 NCBIGene:27202
7067 1750-1753 GeneOrGeneProduct denotes ASP NCBIGene:718
7068 1824-1829 DiseaseOrPhenotypicFeature denotes obese MESH:D009765
7069 1913-1916 GeneOrGeneProduct denotes ASP NCBIGene:718
7070 1921-1923 ChemicalEntity denotes TG MESH:D014280

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 120-134 DiseaseOrPhenotypicFeature denotes morbidly obese 0005139
T2 1815-1829 DiseaseOrPhenotypicFeature denotes morbidly obese 0005139

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 36-39 GeneOrGeneProduct denotes ASP
T2 102-109 GeneOrGeneProduct denotes adipose
T3 129-134 GeneOrGeneProduct denotes obese
T4 171-178 GeneOrGeneProduct denotes obesity
T5 227-232 GeneOrGeneProduct denotes obese
T6 252-259 GeneOrGeneProduct denotes insulin
T7 282-292 GeneOrGeneProduct denotes production
T8 313-318 GeneOrGeneProduct denotes Based
T9 322-329 GeneOrGeneProduct denotes fasting
T10 347-352 GeneOrGeneProduct denotes obese
T11 404-411 GeneOrGeneProduct denotes protein
T12 413-416 GeneOrGeneProduct denotes ASP
T13 422-434 GeneOrGeneProduct denotes Triglyceride
T14 436-438 GeneOrGeneProduct denotes TG
T15 441-444 GeneOrGeneProduct denotes LAT
T16 449-453 GeneOrGeneProduct denotes High
T17 454-457 GeneOrGeneProduct denotes ASP
T18 462-464 GeneOrGeneProduct denotes TG
T19 466-469 GeneOrGeneProduct denotes HAT
T20 507-514 GeneOrGeneProduct denotes adipose
T21 524-530 GeneOrGeneProduct denotes n = 21
T22 648-655 GeneOrGeneProduct denotes METHODS
T23 657-660 GeneOrGeneProduct denotes LAT
T24 665-668 GeneOrGeneProduct denotes HAT
T25 697-704 GeneOrGeneProduct denotes obesity
T26 706-713 GeneOrGeneProduct denotes insulin
T27 736-743 GeneOrGeneProduct denotes similar
T28 758-765 GeneOrGeneProduct denotes insulin
T29 781-785 GeneOrGeneProduct denotes InsR
T30 787-792 GeneOrGeneProduct denotes IRS-1
T31 795-798 GeneOrGeneProduct denotes ASP
T32 813-819 GeneOrGeneProduct denotes tended
T33 843-846 GeneOrGeneProduct denotes HAT
T34 874-882 GeneOrGeneProduct denotes factor B
T35 884-891 GeneOrGeneProduct denotes adipsin
T36 893-906 GeneOrGeneProduct denotes complement C3
T37 944-947 GeneOrGeneProduct denotes LAT
T38 952-955 GeneOrGeneProduct denotes HAT
T39 967-973 GeneOrGeneProduct denotes almost
T40 1005-1011 GeneOrGeneProduct denotes little
T41 1047-1051 GeneOrGeneProduct denotes C5L2
T42 1067-1070 GeneOrGeneProduct denotes ASP
T43 1071-1079 GeneOrGeneProduct denotes receptor
T44 1084-1087 GeneOrGeneProduct denotes HAT
T45 1112-1115 GeneOrGeneProduct denotes ASP
T46 1151-1153 GeneOrGeneProduct denotes TG
T47 1172-1175 GeneOrGeneProduct denotes HAT
T48 1176-1183 GeneOrGeneProduct denotes adipose
T49 1247-1251 GeneOrGeneProduct denotes CD36
T50 1253-1258 GeneOrGeneProduct denotes DGAT1
T51 1260-1265 GeneOrGeneProduct denotes DGAT2
T52 1267-1271 GeneOrGeneProduct denotes SCD1
T53 1273-1277 GeneOrGeneProduct denotes FASN
T54 1305-1309 GeneOrGeneProduct denotes CES1
T55 1311-1320 GeneOrGeneProduct denotes perilipin
T56 1329-1333 GeneOrGeneProduct denotes acid
T57 1334-1341 GeneOrGeneProduct denotes binding
T58 1342-1350 GeneOrGeneProduct denotes proteins
T59 1352-1357 GeneOrGeneProduct denotes FABP1
T60 1359-1364 GeneOrGeneProduct denotes FABP3
T61 1405-1414 GeneOrGeneProduct denotes CEBPalpha
T62 1416-1424 GeneOrGeneProduct denotes CEBPbeta
T63 1426-1435 GeneOrGeneProduct denotes PPARgamma
T64 1441-1449 GeneOrGeneProduct denotes contrast
T65 1491-1495 GeneOrGeneProduct denotes AMPK
T66 1497-1501 GeneOrGeneProduct denotes UCP1
T67 1503-1507 GeneOrGeneProduct denotes CPT1
T68 1509-1514 GeneOrGeneProduct denotes FABP7
T69 1517-1520 GeneOrGeneProduct denotes HAT
T70 1568-1573 GeneOrGeneProduct denotes TGFB1
T71 1575-1580 GeneOrGeneProduct denotes TIMP1
T72 1582-1587 GeneOrGeneProduct denotes TIMP3
T73 1593-1598 GeneOrGeneProduct denotes TIMP4
T74 1621-1625 GeneOrGeneProduct denotes PIG7
T75 1630-1634 GeneOrGeneProduct denotes MMP2
T76 1670-1673 GeneOrGeneProduct denotes all
T77 1735-1739 GeneOrGeneProduct denotes C5L2
T78 1740-1748 GeneOrGeneProduct denotes receptor
T79 1750-1753 GeneOrGeneProduct denotes ASP
T80 1784-1791 GeneOrGeneProduct denotes factors
T81 1795-1802 GeneOrGeneProduct denotes adipose
T82 1824-1829 GeneOrGeneProduct denotes obese
T83 1830-1833 GeneOrGeneProduct denotes HAT
T84 1854-1875 GeneOrGeneProduct denotes compensatory response
T85 1913-1916 GeneOrGeneProduct denotes ASP
T86 1921-1923 GeneOrGeneProduct denotes TG

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 36-39 GeneOrGeneProduct denotes ASP
T2 102-109 GeneOrGeneProduct denotes adipose
T3 129-134 GeneOrGeneProduct denotes obese
T4 227-232 GeneOrGeneProduct denotes obese
T5 252-259 GeneOrGeneProduct denotes insulin
T6 347-352 GeneOrGeneProduct denotes obese
T7 404-411 GeneOrGeneProduct denotes protein
T8 413-416 GeneOrGeneProduct denotes ASP
T9 422-434 GeneOrGeneProduct denotes Triglyceride
T10 436-438 GeneOrGeneProduct denotes TG
T11 454-457 GeneOrGeneProduct denotes ASP
T12 462-464 GeneOrGeneProduct denotes TG
T13 507-514 GeneOrGeneProduct denotes adipose
T14 706-713 GeneOrGeneProduct denotes insulin
T15 736-743 GeneOrGeneProduct denotes similar
T16 758-765 GeneOrGeneProduct denotes insulin
T17 781-785 GeneOrGeneProduct denotes InsR
T18 787-792 GeneOrGeneProduct denotes IRS-1
T19 795-798 GeneOrGeneProduct denotes ASP
T20 874-882 GeneOrGeneProduct denotes factor B
T21 884-891 GeneOrGeneProduct denotes adipsin
T22 893-906 GeneOrGeneProduct denotes complement C3
T23 1005-1011 GeneOrGeneProduct denotes little
T24 1047-1051 GeneOrGeneProduct denotes C5L2
T25 1067-1070 GeneOrGeneProduct denotes ASP
T26 1071-1079 GeneOrGeneProduct denotes receptor
T27 1112-1115 GeneOrGeneProduct denotes ASP
T28 1151-1153 GeneOrGeneProduct denotes TG
T29 1176-1183 GeneOrGeneProduct denotes adipose
T30 1247-1251 GeneOrGeneProduct denotes CD36
T31 1253-1258 GeneOrGeneProduct denotes DGAT1
T32 1260-1265 GeneOrGeneProduct denotes DGAT2
T33 1267-1271 GeneOrGeneProduct denotes SCD1
T34 1273-1277 GeneOrGeneProduct denotes FASN
T35 1305-1309 GeneOrGeneProduct denotes CES1
T36 1311-1320 GeneOrGeneProduct denotes perilipin
T37 1329-1333 GeneOrGeneProduct denotes acid
T38 1334-1341 GeneOrGeneProduct denotes binding
T39 1352-1357 GeneOrGeneProduct denotes FABP1
T40 1359-1364 GeneOrGeneProduct denotes FABP3
T41 1405-1414 GeneOrGeneProduct denotes CEBPalpha
T42 1416-1424 GeneOrGeneProduct denotes CEBPbeta
T43 1426-1435 GeneOrGeneProduct denotes PPARgamma
T44 1491-1495 GeneOrGeneProduct denotes AMPK
T45 1497-1501 GeneOrGeneProduct denotes UCP1
T46 1503-1507 GeneOrGeneProduct denotes CPT1
T47 1509-1514 GeneOrGeneProduct denotes FABP7
T48 1568-1573 GeneOrGeneProduct denotes TGFB1
T49 1575-1580 GeneOrGeneProduct denotes TIMP1
T50 1582-1587 GeneOrGeneProduct denotes TIMP3
T51 1593-1598 GeneOrGeneProduct denotes TIMP4
T52 1621-1625 GeneOrGeneProduct denotes PIG7
T53 1630-1634 GeneOrGeneProduct denotes MMP2
T54 1735-1739 GeneOrGeneProduct denotes C5L2
T55 1740-1748 GeneOrGeneProduct denotes receptor
T56 1750-1753 GeneOrGeneProduct denotes ASP
T57 1795-1802 GeneOrGeneProduct denotes adipose
T58 1824-1829 GeneOrGeneProduct denotes obese
T59 1854-1875 GeneOrGeneProduct denotes compensatory response
T60 1913-1916 GeneOrGeneProduct denotes ASP
T61 1921-1923 GeneOrGeneProduct denotes TG

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 129-134 DiseaseOrPhenotypicFeature denotes obese DISEASE
T2 171-178 DiseaseOrPhenotypicFeature denotes obesity D009765
T3 227-232 DiseaseOrPhenotypicFeature denotes obese DISEASE
T4 252-270 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T5 347-352 DiseaseOrPhenotypicFeature denotes obese DISEASE
T6 607-619 DiseaseOrPhenotypicFeature denotes inflammation D007249
T7 697-704 DiseaseOrPhenotypicFeature denotes obesity D009765
T8 1549-1561 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T9 1605-1620 DiseaseOrPhenotypicFeature denotes proinflammatory DISEASE
T10 1824-1829 DiseaseOrPhenotypicFeature denotes obese DISEASE

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 36-39 GeneOrGeneProduct denotes ASP
T2 382-411 GeneOrGeneProduct denotes Acylation Stimulating protein
T3 413-416 GeneOrGeneProduct denotes ASP
T4 454-457 GeneOrGeneProduct denotes ASP
T5 758-773 GeneOrGeneProduct denotes insulin-related
T6 781-785 GeneOrGeneProduct denotes InsR
T7 787-792 GeneOrGeneProduct denotes IRS-1
T8 795-798 GeneOrGeneProduct denotes ASP
T9 874-882 GeneOrGeneProduct denotes factor B
T10 884-891 GeneOrGeneProduct denotes adipsin
T11 893-906 GeneOrGeneProduct denotes complement C3
T12 1047-1051 GeneOrGeneProduct denotes C5L2
T13 1067-1070 GeneOrGeneProduct denotes ASP
T14 1112-1115 GeneOrGeneProduct denotes ASP
T15 1247-1251 GeneOrGeneProduct denotes CD36
T16 1253-1258 GeneOrGeneProduct denotes DGAT1
T17 1260-1265 GeneOrGeneProduct denotes DGAT2
T18 1267-1271 GeneOrGeneProduct denotes SCD1
T19 1273-1277 GeneOrGeneProduct denotes FASN
T20 1305-1309 GeneOrGeneProduct denotes CES1
T21 1311-1320 GeneOrGeneProduct denotes perilipin
T22 1323-1350 GeneOrGeneProduct denotes fatty acid binding proteins
T23 1352-1357 GeneOrGeneProduct denotes FABP1
T24 1359-1364 GeneOrGeneProduct denotes FABP3
T25 1405-1414 GeneOrGeneProduct denotes CEBPalpha
T26 1416-1424 GeneOrGeneProduct denotes CEBPbeta
T27 1426-1435 GeneOrGeneProduct denotes PPARgamma
T28 1491-1495 GeneOrGeneProduct denotes AMPK
T29 1497-1501 GeneOrGeneProduct denotes UCP1
T30 1503-1507 GeneOrGeneProduct denotes CPT1
T31 1509-1514 GeneOrGeneProduct denotes FABP7
T32 1568-1573 GeneOrGeneProduct denotes TGFB1
T33 1575-1580 GeneOrGeneProduct denotes TIMP1
T34 1582-1587 GeneOrGeneProduct denotes TIMP3
T35 1593-1598 GeneOrGeneProduct denotes TIMP4
T36 1621-1625 GeneOrGeneProduct denotes PIG7
T37 1630-1634 GeneOrGeneProduct denotes MMP2
T38 1735-1739 GeneOrGeneProduct denotes C5L2
T39 1750-1753 GeneOrGeneProduct denotes ASP
T40 1854-1875 GeneOrGeneProduct denotes compensatory response
T41 1913-1916 GeneOrGeneProduct denotes ASP

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 171-178 DiseaseOrPhenotypicFeature denotes obesity 0011122
T2 466-469 DiseaseOrPhenotypicFeature denotes HAT 0018048
T3 503-505 DiseaseOrPhenotypicFeature denotes OM 0006325
T4 665-668 DiseaseOrPhenotypicFeature denotes HAT 0018048
T5 697-704 DiseaseOrPhenotypicFeature denotes obesity 0011122
T6 787-790 DiseaseOrPhenotypicFeature denotes IRS 0100185
T7 843-846 DiseaseOrPhenotypicFeature denotes HAT 0018048
T8 952-955 DiseaseOrPhenotypicFeature denotes HAT 0018048
T9 1026-1028 DiseaseOrPhenotypicFeature denotes OM 0006325
T10 1084-1087 DiseaseOrPhenotypicFeature denotes HAT 0018048
T11 1172-1175 DiseaseOrPhenotypicFeature denotes HAT 0018048
T12 1517-1520 DiseaseOrPhenotypicFeature denotes HAT 0018048
T13 1830-1833 DiseaseOrPhenotypicFeature denotes HAT 0018048

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 129-134 DiseaseOrPhenotypicFeature denotes obese DISEASE
T2 171-178 DiseaseOrPhenotypicFeature denotes obesity D009765
T3 227-232 DiseaseOrPhenotypicFeature denotes obese DISEASE
T4 252-270 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T5 347-352 DiseaseOrPhenotypicFeature denotes obese DISEASE
T6 607-619 DiseaseOrPhenotypicFeature denotes inflammation DISEASE|D007249
T8 697-704 DiseaseOrPhenotypicFeature denotes obesity D009765
T9 1549-1561 DiseaseOrPhenotypicFeature denotes inflammatory DISEASE
T10 1605-1620 DiseaseOrPhenotypicFeature denotes proinflammatory DISEASE
T11 1824-1829 DiseaseOrPhenotypicFeature denotes obese DISEASE

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 129-134 DiseaseOrPhenotypicFeature denotes obese DISEASE
T2 171-178 DiseaseOrPhenotypicFeature denotes obesity D009765
T3 227-232 DiseaseOrPhenotypicFeature denotes obese DISEASE
T4 252-270 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T5 347-352 DiseaseOrPhenotypicFeature denotes obese DISEASE
T6 607-619 DiseaseOrPhenotypicFeature denotes inflammation D007249
T7 697-704 DiseaseOrPhenotypicFeature denotes obesity D009765
T8 1605-1620 DiseaseOrPhenotypicFeature denotes proinflammatory DISEASE
T9 1824-1829 DiseaseOrPhenotypicFeature denotes obese DISEASE

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 422-434 ChemicalEntity denotes Triglyceride http://purl.obolibrary.org/obo/CHEBI_90073|http://purl.obolibrary.org/obo/CHEBI_90072|http://purl.obolibrary.org/obo/CHEBI_90070|http://purl.obolibrary.org/obo/CHEBI_90069|http://purl.obolibrary.org/obo/CHEBI_90067|http://purl.obolibrary.org/obo/CHEBI_90066|http://purl.obolibrary.org/obo/CHEBI_90054|http://purl.obolibrary.org/obo/CHEBI_90053|http://purl.obolibrary.org/obo/CHEBI_90052|http://purl.obolibrary.org/obo/CHEBI_90051|http://purl.obolibrary.org/obo/CHEBI_90050|http://purl.obolibrary.org/obo/CHEBI_90049|http://purl.obolibrary.org/obo/CHEBI_90048|http://purl.obolibrary.org/obo/CHEBI_90047|http://purl.obolibrary.org/obo/CHEBI_90042|http://purl.obolibrary.org/obo/CHEBI_89971|http://purl.obolibrary.org/obo/CHEBI_89962|http://purl.obolibrary.org/obo/CHEBI_89961|http://purl.obolibrary.org/obo/CHEBI_89960|http://purl.obolibrary.org/obo/CHEBI_89959|http://purl.obolibrary.org/obo/CHEBI_89958|http://purl.obolibrary.org/obo/CHEBI_89952|http://purl.obolibrary.org/obo/CHEBI_89950|http://purl.obolibrary.org/obo/CHEBI_89948|http://purl.obolibrary.org/obo/CHEBI_89842|http://purl.obolibrary.org/obo/CHEBI_89841|http://purl.obolibrary.org/obo/CHEBI_89840|http://purl.obolibrary.org/obo/CHEBI_89779|http://purl.obolibrary.org/obo/CHEBI_89777|http://purl.obolibrary.org/obo/CHEBI_89776|http://purl.obolibrary.org/obo/CHEBI_89775|http://purl.obolibrary.org/obo/CHEBI_89774|http://purl.obolibrary.org/obo/CHEBI_89772|http://purl.obolibrary.org/obo/CHEBI_89768|http://purl.obolibrary.org/obo/CHEBI_89767|http://purl.obolibrary.org/obo/CHEBI_89765|http://purl.obolibrary.org/obo/CHEBI_89764|http://purl.obolibrary.org/obo/CHEBI_89763|http://purl.obolibrary.org/obo/CHEBI_89759|http://purl.obolibrary.org/obo/CHEBI_89758|http://purl.obolibrary.org/obo/CHEBI_89757|http://purl.obolibrary.org/obo/CHEBI_89756|http://purl.obolibrary.org/obo/CHEBI_89754|http://purl.obolibrary.org/obo/CHEBI_89166|http://purl.obolibrary.org/obo/CHEBI_89025|http://purl.obolibrary.org/obo/CHEBI_89024|http://purl.obolibrary.org/obo/CHEBI_89023|http://purl.obolibrary.org/obo/CHEBI_89022|http://purl.obolibrary.org/obo/CHEBI_89021|http://purl.obolibrary.org/obo/CHEBI_89020|http://purl.obolibrary.org/obo/CHEBI_89019|http://purl.obolibrary.org/obo/CHEBI_89018|http://purl.obolibrary.org/obo/CHEBI_89017|http://purl.obolibrary.org/obo/CHEBI_89016|http://purl.obolibrary.org/obo/CHEBI_89011|http://purl.obolibrary.org/obo/CHEBI_89005|http://purl.obolibrary.org/obo/CHEBI_89003|http://purl.obolibrary.org/obo/CHEBI_89001|http://purl.obolibrary.org/obo/CHEBI_88999|http://purl.obolibrary.org/obo/CHEBI_88998|http://purl.obolibrary.org/obo/CHEBI_88997|http://purl.obolibrary.org/obo/CHEBI_88995|http://purl.obolibrary.org/obo/CHEBI_88994|http://purl.obolibrary.org/obo/CHEBI_88993|http://purl.obolibrary.org/obo/CHEBI_88987|http://purl.obolibrary.org/obo/CHEBI_88986|http://purl.obolibrary.org/obo/CHEBI_88985|http://purl.obolibrary.org/obo/CHEBI_88984|http://purl.obolibrary.org/obo/CHEBI_88983|http://purl.obolibrary.org/obo/CHEBI_88982|http://purl.obolibrary.org/obo/CHEBI_88980|http://purl.obolibrary.org/obo/CHEBI_88979|http://purl.obolibrary.org/obo/CHEBI_88978|http://purl.obolibrary.org/obo/CHEBI_88977|http://purl.obolibrary.org/obo/CHEBI_88976|http://purl.obolibrary.org/obo/CHEBI_88973|http://purl.obolibrary.org/obo/CHEBI_88972|http://purl.obolibrary.org/obo/CHEBI_88971|http://purl.obolibrary.org/obo/CHEBI_88970|http://purl.obolibrary.org/obo/CHEBI_88968|http://purl.obolibrary.org/obo/CHEBI_88967|http://purl.obolibrary.org/obo/CHEBI_88946|http://purl.obolibrary.org/obo/CHEBI_88945|http://purl.obolibrary.org/obo/CHEBI_88943|http://purl.obolibrary.org/obo/CHEBI_88941|http://purl.obolibrary.org/obo/CHEBI_88940|http://purl.obolibrary.org/obo/CHEBI_88901|http://purl.obolibrary.org/obo/CHEBI_88899|http://purl.obolibrary.org/obo/CHEBI_88898|http://purl.obolibrary.org/obo/CHEBI_88892|http://purl.obolibrary.org/obo/CHEBI_88891|http://purl.obolibrary.org/obo/CHEBI_88890|http://purl.obolibrary.org/obo/CHEBI_88882|http://purl.obolibrary.org/obo/CHEBI_88881|http://purl.obolibrary.org/obo/CHEBI_88880|http://purl.obolibrary.org/obo/CHEBI_88875|http://purl.obolibrary.org/obo/CHEBI_17855
T98 436-438 ChemicalEntity denotes TG http://purl.obolibrary.org/obo/CHEBI_90073
T99 462-464 ChemicalEntity denotes TG http://purl.obolibrary.org/obo/CHEBI_90073
T100 719-726 ChemicalEntity denotes glucose D005947|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_17234
T103 1151-1153 ChemicalEntity denotes TG http://purl.obolibrary.org/obo/CHEBI_90073
T104 1300-1303 ChemicalEntity denotes HSL http://purl.obolibrary.org/obo/CHEBI_17289
T105 1380-1403 ChemicalEntity denotes differentiation markers D000943
T106 1921-1923 ChemicalEntity denotes TG http://purl.obolibrary.org/obo/CHEBI_90073

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T106 1921-1923 ChemicalEntity denotes TG http://purl.obolibrary.org/obo/CHEBI_90073
T105 1380-1403 ChemicalEntity denotes differentiation markers D000943
T104 1300-1303 ChemicalEntity denotes HSL http://purl.obolibrary.org/obo/CHEBI_17289
T103 1151-1153 ChemicalEntity denotes TG http://purl.obolibrary.org/obo/CHEBI_90073
T100 719-726 ChemicalEntity denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167|D005947
T99 462-464 ChemicalEntity denotes TG http://purl.obolibrary.org/obo/CHEBI_90073
T98 436-438 ChemicalEntity denotes TG http://purl.obolibrary.org/obo/CHEBI_90073
T1 422-434 ChemicalEntity denotes Triglyceride http://purl.obolibrary.org/obo/CHEBI_17855|http://purl.obolibrary.org/obo/CHEBI_88875|http://purl.obolibrary.org/obo/CHEBI_88880|http://purl.obolibrary.org/obo/CHEBI_88881|http://purl.obolibrary.org/obo/CHEBI_88882|http://purl.obolibrary.org/obo/CHEBI_88890|http://purl.obolibrary.org/obo/CHEBI_88891|http://purl.obolibrary.org/obo/CHEBI_88892|http://purl.obolibrary.org/obo/CHEBI_88898|http://purl.obolibrary.org/obo/CHEBI_88899|http://purl.obolibrary.org/obo/CHEBI_88901|http://purl.obolibrary.org/obo/CHEBI_88940|http://purl.obolibrary.org/obo/CHEBI_88941|http://purl.obolibrary.org/obo/CHEBI_88943|http://purl.obolibrary.org/obo/CHEBI_88945|http://purl.obolibrary.org/obo/CHEBI_88946|http://purl.obolibrary.org/obo/CHEBI_88967|http://purl.obolibrary.org/obo/CHEBI_88968|http://purl.obolibrary.org/obo/CHEBI_88970|http://purl.obolibrary.org/obo/CHEBI_88971|http://purl.obolibrary.org/obo/CHEBI_88972|http://purl.obolibrary.org/obo/CHEBI_88973|http://purl.obolibrary.org/obo/CHEBI_88976|http://purl.obolibrary.org/obo/CHEBI_88977|http://purl.obolibrary.org/obo/CHEBI_88978|http://purl.obolibrary.org/obo/CHEBI_88979|http://purl.obolibrary.org/obo/CHEBI_88980|http://purl.obolibrary.org/obo/CHEBI_88982|http://purl.obolibrary.org/obo/CHEBI_88983|http://purl.obolibrary.org/obo/CHEBI_88984|http://purl.obolibrary.org/obo/CHEBI_88985|http://purl.obolibrary.org/obo/CHEBI_88986|http://purl.obolibrary.org/obo/CHEBI_88987|http://purl.obolibrary.org/obo/CHEBI_88993|http://purl.obolibrary.org/obo/CHEBI_88994|http://purl.obolibrary.org/obo/CHEBI_88995|http://purl.obolibrary.org/obo/CHEBI_88997|http://purl.obolibrary.org/obo/CHEBI_88998|http://purl.obolibrary.org/obo/CHEBI_88999|http://purl.obolibrary.org/obo/CHEBI_89001|http://purl.obolibrary.org/obo/CHEBI_89003|http://purl.obolibrary.org/obo/CHEBI_89005|http://purl.obolibrary.org/obo/CHEBI_89011|http://purl.obolibrary.org/obo/CHEBI_89016|http://purl.obolibrary.org/obo/CHEBI_89017|http://purl.obolibrary.org/obo/CHEBI_89018|http://purl.obolibrary.org/obo/CHEBI_89019|http://purl.obolibrary.org/obo/CHEBI_89020|http://purl.obolibrary.org/obo/CHEBI_89021|http://purl.obolibrary.org/obo/CHEBI_89022|http://purl.obolibrary.org/obo/CHEBI_89023|http://purl.obolibrary.org/obo/CHEBI_89024|http://purl.obolibrary.org/obo/CHEBI_89025|http://purl.obolibrary.org/obo/CHEBI_89166|http://purl.obolibrary.org/obo/CHEBI_89754|http://purl.obolibrary.org/obo/CHEBI_89756|http://purl.obolibrary.org/obo/CHEBI_89757|http://purl.obolibrary.org/obo/CHEBI_89758|http://purl.obolibrary.org/obo/CHEBI_89759|http://purl.obolibrary.org/obo/CHEBI_89763|http://purl.obolibrary.org/obo/CHEBI_89764|http://purl.obolibrary.org/obo/CHEBI_89765|http://purl.obolibrary.org/obo/CHEBI_89767|http://purl.obolibrary.org/obo/CHEBI_89768|http://purl.obolibrary.org/obo/CHEBI_89772|http://purl.obolibrary.org/obo/CHEBI_89774|http://purl.obolibrary.org/obo/CHEBI_89775|http://purl.obolibrary.org/obo/CHEBI_89776|http://purl.obolibrary.org/obo/CHEBI_89777|http://purl.obolibrary.org/obo/CHEBI_89779|http://purl.obolibrary.org/obo/CHEBI_89840|http://purl.obolibrary.org/obo/CHEBI_89841|http://purl.obolibrary.org/obo/CHEBI_89842|http://purl.obolibrary.org/obo/CHEBI_89948|http://purl.obolibrary.org/obo/CHEBI_89950|http://purl.obolibrary.org/obo/CHEBI_89952|http://purl.obolibrary.org/obo/CHEBI_89958|http://purl.obolibrary.org/obo/CHEBI_89959|http://purl.obolibrary.org/obo/CHEBI_89960|http://purl.obolibrary.org/obo/CHEBI_89961|http://purl.obolibrary.org/obo/CHEBI_89962|http://purl.obolibrary.org/obo/CHEBI_89971|http://purl.obolibrary.org/obo/CHEBI_90042|http://purl.obolibrary.org/obo/CHEBI_90047|http://purl.obolibrary.org/obo/CHEBI_90048|http://purl.obolibrary.org/obo/CHEBI_90049|http://purl.obolibrary.org/obo/CHEBI_90050|http://purl.obolibrary.org/obo/CHEBI_90051|http://purl.obolibrary.org/obo/CHEBI_90052|http://purl.obolibrary.org/obo/CHEBI_90053|http://purl.obolibrary.org/obo/CHEBI_90054|http://purl.obolibrary.org/obo/CHEBI_90066|http://purl.obolibrary.org/obo/CHEBI_90067|http://purl.obolibrary.org/obo/CHEBI_90069|http://purl.obolibrary.org/obo/CHEBI_90070|http://purl.obolibrary.org/obo/CHEBI_90072|http://purl.obolibrary.org/obo/CHEBI_90073
T41 1913-1916 GeneOrGeneProduct denotes ASP
T40 1854-1875 GeneOrGeneProduct denotes compensatory response
T39 1750-1753 GeneOrGeneProduct denotes ASP
T38 1735-1739 GeneOrGeneProduct denotes C5L2
T37 1630-1634 GeneOrGeneProduct denotes MMP2
T36 1621-1625 GeneOrGeneProduct denotes PIG7
T35 1593-1598 GeneOrGeneProduct denotes TIMP4
T34 1582-1587 GeneOrGeneProduct denotes TIMP3
T33 1575-1580 GeneOrGeneProduct denotes TIMP1
T32 1568-1573 GeneOrGeneProduct denotes TGFB1
T31 1509-1514 GeneOrGeneProduct denotes FABP7
T30 1503-1507 GeneOrGeneProduct denotes CPT1
T29 1497-1501 GeneOrGeneProduct denotes UCP1
T28 1491-1495 GeneOrGeneProduct denotes AMPK
T27 1426-1435 GeneOrGeneProduct denotes PPARgamma
T26 1416-1424 GeneOrGeneProduct denotes CEBPbeta
T25 1405-1414 GeneOrGeneProduct denotes CEBPalpha
T24 1359-1364 GeneOrGeneProduct denotes FABP3
T23 1352-1357 GeneOrGeneProduct denotes FABP1
T22 1323-1350 GeneOrGeneProduct denotes fatty acid binding proteins
T21 1311-1320 GeneOrGeneProduct denotes perilipin
T20 1305-1309 GeneOrGeneProduct denotes CES1
T19 1273-1277 GeneOrGeneProduct denotes FASN
T18 1267-1271 GeneOrGeneProduct denotes SCD1
T17 1260-1265 GeneOrGeneProduct denotes DGAT2
T16 1253-1258 GeneOrGeneProduct denotes DGAT1
T15 1247-1251 GeneOrGeneProduct denotes CD36
T14 1112-1115 GeneOrGeneProduct denotes ASP
T13 1067-1070 GeneOrGeneProduct denotes ASP
T12 1047-1051 GeneOrGeneProduct denotes C5L2
T11 893-906 GeneOrGeneProduct denotes complement C3
T10 884-891 GeneOrGeneProduct denotes adipsin
T9 874-882 GeneOrGeneProduct denotes factor B
T8 795-798 GeneOrGeneProduct denotes ASP
T7 787-792 GeneOrGeneProduct denotes IRS-1
T6 781-785 GeneOrGeneProduct denotes InsR
T5 758-773 GeneOrGeneProduct denotes insulin-related
T4 454-457 GeneOrGeneProduct denotes ASP
T3 413-416 GeneOrGeneProduct denotes ASP
T2 382-411 GeneOrGeneProduct denotes Acylation Stimulating protein
T58896 36-39 GeneOrGeneProduct denotes ASP
T88115 1824-1829 DiseaseOrPhenotypicFeature denotes obese DISEASE
T85124 1605-1620 DiseaseOrPhenotypicFeature denotes proinflammatory DISEASE
T76064 697-704 DiseaseOrPhenotypicFeature denotes obesity D009765
T27000 607-619 DiseaseOrPhenotypicFeature denotes inflammation D007249
T12227 347-352 DiseaseOrPhenotypicFeature denotes obese DISEASE
T72653 252-270 DiseaseOrPhenotypicFeature denotes insulin resistance D007333
T58742 227-232 DiseaseOrPhenotypicFeature denotes obese DISEASE
T75442 171-178 DiseaseOrPhenotypicFeature denotes obesity D009765
T83305 129-134 DiseaseOrPhenotypicFeature denotes obese DISEASE

DisGeNET

Id Subject Object Predicate Lexical cue
T0 1735-1739 gene:27202 denotes C5L2
T1 1824-1829 disease:C0028754 denotes obese
T2 1750-1753 gene:259266 denotes ASP
T3 1824-1829 disease:C0028754 denotes obese
T4 1750-1753 gene:718 denotes ASP
T5 1824-1829 disease:C0028754 denotes obese
T6 1750-1753 gene:443 denotes ASP
T7 1824-1829 disease:C0028754 denotes obese
T8 1750-1753 gene:9474 denotes ASP
T9 1824-1829 disease:C0028754 denotes obese
T10 1750-1753 gene:29974 denotes ASP
T11 1824-1829 disease:C0028754 denotes obese
T12 1750-1753 gene:434 denotes ASP
T13 1824-1829 disease:C0028754 denotes obese
T14 1750-1753 gene:83853 denotes ASP
T15 1824-1829 disease:C0028754 denotes obese
R1 T0 T1 associated_with C5L2,obese
R2 T2 T3 associated_with ASP,obese
R3 T4 T5 associated_with ASP,obese
R4 T6 T7 associated_with ASP,obese
R5 T8 T9 associated_with ASP,obese
R6 T10 T11 associated_with ASP,obese
R7 T12 T13 associated_with ASP,obese
R8 T14 T15 associated_with ASP,obese

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 171-178 HP_0001513 denotes obesity
T2 227-232 HP_0001513 denotes obese
T3 252-270 HP_0000855 denotes insulin resistance
T4 347-352 HP_0001513 denotes obese

Allie

Id Subject Object Predicate Lexical cue
SS1_20105310_4_0 382-411 expanded denotes Acylation Stimulating protein
SS2_20105310_4_0 413-416 abbr denotes ASP
SS1_20105310_4_1 422-434 expanded denotes Triglyceride
SS2_20105310_4_1 436-438 abbr denotes TG
SS1_20105310_4_2 449-464 expanded denotes High ASP and TG
SS2_20105310_4_2 466-469 abbr denotes HAT
SS1_20105310_5_0 472-484 expanded denotes Subcutaneous
SS2_20105310_5_0 486-488 abbr denotes SC
SS1_20105310_5_1 494-501 expanded denotes omental
SS2_20105310_5_1 503-505 abbr denotes OM
AE1_20105310_4_0 SS1_20105310_4_0 SS2_20105310_4_0 abbreviatedTo Acylation Stimulating protein,ASP
AE1_20105310_4_1 SS1_20105310_4_1 SS2_20105310_4_1 abbreviatedTo Triglyceride,TG
AE1_20105310_4_2 SS1_20105310_4_2 SS2_20105310_4_2 abbreviatedTo High ASP and TG,HAT
AE1_20105310_5_0 SS1_20105310_5_0 SS2_20105310_5_0 abbreviatedTo Subcutaneous,SC
AE1_20105310_5_1 SS1_20105310_5_1 SS2_20105310_5_1 abbreviatedTo omental,OM

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
20105310-12#46#49#gene29974 1750-1753 gene29974 denotes ASP
20105310-12#46#49#gene434 1750-1753 gene434 denotes ASP
20105310-12#46#49#gene443 1750-1753 gene443 denotes ASP
20105310-12#46#49#gene259266 1750-1753 gene259266 denotes ASP
20105310-12#46#49#gene9474 1750-1753 gene9474 denotes ASP
20105310-12#46#49#gene718 1750-1753 gene718 denotes ASP
20105310-12#46#49#gene83853 1750-1753 gene83853 denotes ASP
20105310-12#31#35#gene27202 1735-1739 gene27202 denotes C5L2
20105310-12#120#125#diseaseC0028754 1824-1829 diseaseC0028754 denotes obese
46#49#gene29974120#125#diseaseC0028754 20105310-12#46#49#gene29974 20105310-12#120#125#diseaseC0028754 associated_with ASP,obese
46#49#gene434120#125#diseaseC0028754 20105310-12#46#49#gene434 20105310-12#120#125#diseaseC0028754 associated_with ASP,obese
46#49#gene443120#125#diseaseC0028754 20105310-12#46#49#gene443 20105310-12#120#125#diseaseC0028754 associated_with ASP,obese
46#49#gene259266120#125#diseaseC0028754 20105310-12#46#49#gene259266 20105310-12#120#125#diseaseC0028754 associated_with ASP,obese
46#49#gene9474120#125#diseaseC0028754 20105310-12#46#49#gene9474 20105310-12#120#125#diseaseC0028754 associated_with ASP,obese
46#49#gene718120#125#diseaseC0028754 20105310-12#46#49#gene718 20105310-12#120#125#diseaseC0028754 associated_with ASP,obese
46#49#gene83853120#125#diseaseC0028754 20105310-12#46#49#gene83853 20105310-12#120#125#diseaseC0028754 associated_with ASP,obese
31#35#gene27202120#125#diseaseC0028754 20105310-12#31#35#gene27202 20105310-12#120#125#diseaseC0028754 associated_with C5L2,obese